It will be required to analyse other models of sepsis in vivo including single and polymicrobial to confirm if GzmK is a minor regulator during bacterial sepsis, and, thus, design proper protocols to use the Gzm family as new therapeutic targets in sepsis. The gene discussed is GZMK; the disease is bacterial infectious disease with sepsis.